Company Filing History:
Years Active: 2021
Title: The Innovative Contributions of Anthony W. Tolcher
Introduction
Anthony W. Tolcher is a notable inventor based in San Antonio, TX (US). He has made significant contributions to the field of medical research, particularly in the treatment of tumor diseases. His innovative work has led to the development of methods and compositions that aim to improve patient outcomes in oncology.
Latest Patents
Anthony W. Tolcher holds a patent for "Methods and compositions for treating tumor diseases." This invention provides methods for treating tumors in human subjects by inhibiting IGF-1 receptor signaling. It also includes methods for determining the likelihood of a tumor's response to such treatment. The patent features fully human, humanized, or chimeric anti-IGF-1R antibodies that bind to human IGF-1R, along with various fragments and derivatives of these antibodies. Additionally, it encompasses nucleic acids encoding these antibodies and methods for using them in treating or diagnosing IGF-1R-related disorders.
Career Highlights
Tolcher is associated with Amgen Inc., a leading biotechnology company. His work at Amgen has allowed him to focus on groundbreaking research that has the potential to change the landscape of cancer treatment. His dedication to innovation in this field is evident through his patent and ongoing research efforts.
Collaborations
Throughout his career, Anthony W. Tolcher has collaborated with esteemed colleagues, including Pedro J. Beltran and Frank J. Calzone. These collaborations have further enriched his research and contributed to the advancement of cancer therapies.
Conclusion
Anthony W. Tolcher's contributions to the field of oncology through his innovative patent and work at Amgen Inc. highlight his commitment to improving cancer treatment. His research continues to pave the way for new therapeutic approaches that may benefit countless patients in the future.